CVS vs INMD: fair value comparison
CVS Health Corporation and InMode Ltd. · Updated 2026-09-06
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, CVS currently sits closer to the top of our discount ranking. INMD carries the stronger quality grade.
| CVS | INMD | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $96.74 | $15.35 |
| 12-month range | $72.49–$105.37 | $13.59–$16.62 |
| Sector rank | #92 of 113 Healthcare | #93 of 113 Healthcare |
| Quality grade | F | C |
| Leverage | Moderate | Low |
| Margin trend | Stable | — |
| Revenue growth | Modest | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: CVS fair value analysis · INMD fair value analysis